Life Sciences Ontario
Life Sciences Ontario (LSO) strives to be the unified Voice of Life Sciences in Ontario by representing the interests of the diverse life sciences community in the province through advocacy, education, facilitation of economic development and promotion of the industry locally, nationally and internationally. Together we are a strong, innovative sector with significant socioeconomic contributions to the province of Ontario. We hope you will consider joining LSO and help us to achieve our vision for Ontario'€™s life sciences sector - "Diversity of Members, Unity of Voice".


Ontario Genomics appoints new President and CEO

Wednesday, May 24, 2017

Bettina Hamelin has been appointed President and Chief Executive Officer (CEO) of Ontario Genomics (OG), a not-for-profit organization dedicated to catalyzing and advancing genomics innovation within Ontario. Dr. Hamelin will join OGs board and will assume the CEO role effective August 01, 2017.

[Read more here]


University of Guelph Gets Largest-Ever Gift, $20 Million to Lead Agri-Food Revolution

Monday, April 3, 2017

The University of Guelph has received its single largest-ever gift: a $20-million donation from the Arrell Family Foundation to transform the global food economy and further strengthen U of G and Canada as agri-food leaders.

This landmark gift will allow our University to address the defining challenge of our time: food security, safety and sustainability, said U of G president Franco Vaccarino.

[Read more here]


Life Sciences Ontario strengthens its leadership with New Chair, Board Members

Thursday, March 23, 2017

Life Sciences Ontario (LSO) today announced a new Chair of its Board of Directors, along with two new Board members, strengthening its capacity to foster growth and commercialization in Ontarios life sciences sector.

[Read more here]


Canadian collaboration to accelerate development of cancer treatments

Thursday, March 23, 2017

An innovative collaboration between government, industry, and academia aims to accelerate the development of cancer treatments in Canada. The National Research Council of Canada (NRC) and the Toronto-based Centre for the Commercialization of Antibodies and Biologics (CCAB) have put in place over $1M in collaborative agreements over the past year to produce and test therapeutic antibodies discovered at the University of Toronto (U of T).

[Read more here]


Will there be innovation in the Innovation Budget?

Tuesday, March 21, 2017

The Trudeau government, Toronto Star columnist Paul Wells noted, came out of the gate hell-bent on consulting us.

And consult us they did. The Liberals election in October 2015 created renewed optimism for science and knowledge-based industries. They appointed a Minister of Science and shunted science into Industry Canadas nomenclature. Minister Navdeep Bains launched a broad consultation to develop an Innovation Agenda for Canada.

[Read more here]


Algae Dynamics Corp Announces Research Agreement With University Of Waterloo To Investigate Use Of Cannabis Oil In The Context Of Cancer

Friday, February 24, 2017

ALGAE DYNAMICS CORP (OTCQB:ADYNF) (the "Company"), a development stage company focused on the commercialization of its proprietary BioSilo(R) cultivation and extraction system for the growth of algae strains for use in the food and health supplement industry, today announced a research agreement with the University of Waterloo to perform fundamental research on cannabis oil and its constituents in the context of the development and treatment of cancers of the colorectum, pancreas, breast and prostate. The Sponsored Research Agreement is entitled Studies on botanical oils from Algae Dynamics.

[Read more here]